Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-5-20
pubmed:abstractText
Despite all the progress in cancer treatment, glioblastoma, the most malignant tumor of the central nervous system, remains a terminal disease and new therapeutic approaches are urgently needed. A combination of chemotherapy with modifications that lower the apoptotic threshold of cancer cells could be effective. Cathepsin L inhibition was suggested as one of such modifications but the mechanism of cathepsin L anti-apoptotic activity is largely unknown. In the present study we show that, in U87 glioblastoma cells, cathepsin L is present in the nucleus and regulates the transcription of effector caspases 3 and 7. In cells with low cathepsin L expression, p53 and prohibitin--transcription factors that regulate caspase 7 expression--accumulate in the nuclei. The importance of p53 in this process is highlighted by the fact that in U87 cells with inhibited p53 transcriptional activity or in p53-negative cells U251, cathepsin L inhibition did not influence caspase 7 expression and had minimal effect on the level of apoptosis. Since p53 pathways are often mutated in glioblastoma, the findings of our study need to be considered before using cathepsin L inhibition for glioblastoma therapy and suggest that such adjuvant therapy may be effective only for a subpopulation of p53 wild type glioblastoma patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1573-675X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
671-82
pubmed:meshHeading
pubmed-meshheading:21484410-Apoptosis, pubmed-meshheading:21484410-Caspase 3, pubmed-meshheading:21484410-Caspase 7, pubmed-meshheading:21484410-Caspases, pubmed-meshheading:21484410-Cathepsin L, pubmed-meshheading:21484410-Cell Line, Tumor, pubmed-meshheading:21484410-Cell Nucleus, pubmed-meshheading:21484410-Down-Regulation, pubmed-meshheading:21484410-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21484410-Gene Silencing, pubmed-meshheading:21484410-Glioblastoma, pubmed-meshheading:21484410-Humans, pubmed-meshheading:21484410-Lysosomes, pubmed-meshheading:21484410-Mitochondrial Membranes, pubmed-meshheading:21484410-Permeability, pubmed-meshheading:21484410-Protein Transport, pubmed-meshheading:21484410-RNA, Messenger, pubmed-meshheading:21484410-Repressor Proteins, pubmed-meshheading:21484410-Subcellular Fractions, pubmed-meshheading:21484410-Transcription, Genetic, pubmed-meshheading:21484410-Tumor Suppressor Protein p53, pubmed-meshheading:21484410-Up-Regulation
pubmed:year
2011
pubmed:articleTitle
Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7.
pubmed:affiliation
Department of Genetic Toxicology and Cancer Biology, National Institue of Biology, Ljubljana, Slovenia. sasa.kenig@icgeb.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't